TERVISE ARENGU INSTITUUT

Their core work

TAI (National Institute for Health Development) is Estonia's central public health research institution, focused on population health monitoring, health policy analysis, and disease prevention. They contribute epidemiological data, health economics expertise, and national health statistics to European research consortia. Their work spans cancer screening optimization, childhood obesity policy, genomic data infrastructure, and COVID-19 population health research — always bringing the Estonian national health data perspective to multi-country comparative studies.

What they specialise in

How they've shifted over time

TAI's early H2020 work (2015–2018) centered on traditional public health concerns: cancer screening programs, childhood obesity, physical activity tracking, and health economics evaluations. From 2020 onward, their focus shifted decisively toward health data infrastructure — genomic data standards, FAIR data principles, EOSC integration, and population health research infrastructures built in response to COVID-19. This evolution mirrors a broader European trend: moving from disease-specific studies toward building the digital data backbone that supports all future health research.

TAI is positioning itself as a national node for European health data spaces, making them a natural partner for any project requiring Estonian population health data or FAIR-compliant health data infrastructure.

How they like to work

TAI operates exclusively as a participant, never as a coordinator, which is typical for a national health institute contributing country-specific data and expertise to large European consortia. With 97 unique partners across 33 countries from just 4 projects, they consistently join very large multi-country consortia (averaging ~25 partners per project). This makes them an experienced, low-friction partner who knows how to deliver national-level health data within complex international collaborations.

Despite only 4 projects, TAI has built connections with 97 partners across 33 countries — a remarkably wide network driven by participation in large pan-European health consortia. Their reach is genuinely pan-European with no visible geographic bias.

What sets them apart

TAI is Estonia's national public health institute, giving them authoritative access to Estonian population health registries, screening data, and national health statistics — data that no other organization can provide. For consortium builders needing Baltic or Estonian coverage in a multi-country health study, TAI is essentially the default choice. Their recent pivot toward genomic data infrastructure and FAIR standards also positions them at the intersection of traditional public health and the emerging European Health Data Space.

Highlights from their portfolio

• STOP
  Largest funding (EUR 132K) — a major multi-country study on childhood obesity policy combining health economics, cohort data, and intervention evaluation.
• PHIRI
  Built during the COVID-19 crisis, this project created population health research infrastructure for pandemic-era international health data comparisons.
• B1MG
  Part of the 1+ Million Genomes initiative — signals TAI's move into genomic data governance and personalised medicine infrastructure.